References
- Tatemoto K. Neuropeptide Y; the complete amino acid sequence of the brain peptide. Proc Natl Acad Sci USA 1982; 79: 5485–5489
- Lundberg J M, Terenius L, Hökfelt T, Martling C-M, Tatemoto K, Mutt V, Polak J, Bloom S R, Goldstein M. Neuropeptide Y (NPY)- like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand 1932; 116: 477–480
- Lundberg J M, Terenius L, Hökfelt T, Goldstein M. High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man. Neuroscience Letters 1983; 42: 167–172
- Gu J, Adrian T E, Tatemoto K, Polak J M, Allen J M, Bloom S R. Neuropeptide tyrosine (NPY) a major cardiac neuropeptide. Lancet I 1983; 1008–1010
- Lundberg J M, Tatemoto K. Pancreatic polypeptide family (APP, BFP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to α-adrenoceptor blockade. Acta Physiol Scand 1982; 116: 393–402
- Edvinsson L, Emson P, McCulloch J, Tatemoto K, Uddman R, Neuropeptide Y. Cerebrovascular innervation and vasomotor effects in the cat. Neuroscience Letters 1983; 43: 79–84
- Lundberg J M, Stj$aUrne L. Neuropeptide Y (NPY) depresses the secretion of 3H -noradrenaline and the contractile response evoked by field stimulation in the rat vas deferens. Acta Physiol Scand 1984; 120: 477–479
- Allen J M, Tatemoto K, Polak J M, Hughes J, Bloom S R. Two novel related peptides neuropeptide Y (NPY) and peptide YY (PYY) inhibit the contraction of the electrically stimulated mouse vas deferens. Neuropeptides 1982; 3: 71–77
- Lundberg J M, Terenius L, Hökfelt T, Tatemoto K. Comparative immunohistochemical and biochemical analysis of PP-like peptides (NPY, PYY, APP, BPP, $gM-MSH and FMRF-amide) with special reference to presence of neuropeptide Y (NPY) in central and peripheral neurons. J Neuroscience 1984, in press
- Furness J B, Papka R, Della N, Costa M, Eskay R. Substance P–like immunoreactivity in nerves associated with the vascular system of guinea-pigs. Neuroscience 1982; 7: 447–459
- Lundberg J M, Hua X-Y, Franco-Cereceda A. Effects of neuropeptide Y (NPY) on mechanical activity and neurotransmission in the heart, vas deferens and urinary bladder of the guinea-pig. Acta Physiol Scand 1984, in press
- Carlsson A. Drugs which block the storage of 5-hydroxytryptamine and related amines. Handbuch Exp Pharm. 1965; 19: 529–592
- Furness J B, Costa M, Emson P C, H$aRkanson R, Moghimzadeh E, Sundler F, Taylor I L, Chance R E. Distribution pathways and reactions to drug treatment of nerves with neuropeptide Y and pancreatic polypeptide immunoreactivity in the guinea-pig digestive tract. Cell Tissue Res 1983; 234: 71–92
- Allen J M, Bircham P, Edwards A, Tatemoto K, Bloom S R. Neuropeptide Y (NPY) reduces myocardial perfusion and inhibits the force of contraction of the isolated perfused rabbit heart. Regulatory Peptides 1983; 6: 247–253
- Agnati L F, Fuxe K, Benfenati F, Battistini N, H$aUrfstrand A, Hökfelt T, Caviccioli L, Tatemoto K, Mutt V. Failure of neuropeptide Y in vitro to increase the number of α2-adrenergic binding sites in membranes of medulla oblongata of the spontaneously hypertensive rat. Acta Physiol Scand 1983; 119: 309–312
- Green H, Ottis K, Kitchen T. Autonomic stimulation and blockade on canine splenic inflow outflow and weight. Am J Physiol 1960; 198: 424–428
- Brown G L, Davies B N, Ferry C R. The effect of neuronal rest on the output of sympathetic transmitter from the spleen. J Pysiol 1961; 159: 365–380
- Cripps H, Dearnaley D P. Vascular responses and noradrenaline overflows in the isolated, blood-perfused cat spleen: Some effects of cocaine, normetanephrine and α-blocking agents. J Physiol 1972; 227: 647–664
- Dixon W, Mosimann F, Wernér N. The role of presynaptic feedback mechanisms in regulation of norepinephrine release by nerve stimulation. J Pharm Exp Ther 1979; 209: 196–204
- Brown G L, Gillespie J S. The output of sympathetic transmitter from the spleen of the cat. J Physiol 1957; 138: 81–102